Organovo received Nasdaq delisting notice for bid price below $1 per share

VivoSim Labs, INC.

Nasdaq notice on July 18, 2024: closing bid price below $1 for 30 consecutive business days.
180-day compliance period granted until January 14, 2025 to regain bid price rule.
To regain compliance, closing bid must be at least $1 for ten consecutive business days.
Company may consider reverse stock split subject to stockholder approval if not cured.
Trading of ONVO common stock continues on Nasdaq Capital Market without immediate effect.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.